Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation
@article{Bastianelli2018PharmacodynamicsOC, title={Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation}, author={C. Bastianelli and M. Farris and Elena Rosato and I. Brosens and G. Benagiano}, journal={Expert Review of Clinical Pharmacology}, year={2018}, volume={11}, pages={1085 - 1098} }
ABSTRACT Introduction: Following a historical overview, the ovulation-inhibiting effect of various orally administered estrogen-progestin combinations (combined oral contraceptives [COCs]) are examined for their components alone or in the various combined formulations. Special emphasis is given to products containing natural estrogens. Areas covered: Inhibition of ovulation with progestins alone; estrogens alone; various progestins in combination with ethinyl estradiol; various progestins in… CONTINUE READING
Topics from this paper
6 Citations
Pharmacodynamics of combined estrogen–progestin oral contraceptives: 4. Effects on uterine and cervical epithelia
- Medicine
- Expert review of clinical pharmacology
- 2020
- 1
Comparison of the Efficacy and Tolerability of Dienogest and Dienogest Plus Ethinylestradiol on Endometriosis Related-Pain
- Medicine
- 2019
- PDF
A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy.
- Medicine
- Expert opinion on drug safety
- 2020
Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the obstetrician's view.
- Medicine
- Hematology. American Society of Hematology. Education Program
- 2019
- PDF
Current treatment for Polycystic Ovary Syndrome: focus on adolescence.
- Medicine
- Minerva pediatrica
- 2020
- 1
Contraception for the Cardiac Patient: a Cardiologist’s Primer
- Medicine
- Current Treatment Options in Cardiovascular Medicine
- 2020
- PDF
References
SHOWING 1-10 OF 159 REFERENCES
Estrogens in oral contraceptives: historical perspectives.
- Medicine
- The Johns Hopkins medical journal
- 1982
- 8
Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills.
- Medicine
- Best practice & research. Clinical endocrinology & metabolism
- 2013
- 111
Pharmacological and endocrine profiles of gestodene.
- Medicine
- International journal of fertility
- 1987
- 17
- Highly Influential
Comparative studies of the ethynyl estrogens used in oral contraceptives. II. Antiovulatory potency.
- Medicine
- American journal of obstetrics and gynecology
- 1975
- 38
Pharmacology of estrogens and progestogens: influence of different routes of administration
- Medicine
- Climacteric : the journal of the International Menopause Society
- 2005
- 436
- PDF
New knowledge in the physiology of hormonal contraceptives.
- Medicine
- American journal of obstetrics and gynecology
- 1994
- 49
Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
- Medicine
- Contraception
- 1984
- 41
Endogenous estradiol metabolism during treatment with oral contraceptives.
- Medicine
- International journal of clinical pharmacology and therapeutics
- 2004
- 5